If you need help accessing our website, call 855-698-9991
Skip to main content
NYU Langone Provider

Ira M. Jacobson, MD

NYU Langone Provider
  • Specialties: Hepatology, Gastroenterology
  • Treats: Adults
  • Language: English
  • Phone: 212-263-3643
View Scheduling Options

I became fascinated with biology as a child, when my elementary school teacher showed me the teeming life in a drop of pond water through a microscope. My ambition to become a doctor arose from medicine’s ideal combination of science and helping others.

Much later, I decided to specialize in gastroenterology because of the diversity of conditions doctors manage in this field, and the scientific and technologic advances that characterized its dynamic growth early in my medical career. I was particularly fascinated with the liver because of the central role it plays in hundreds of the body’s vital processes.

I devote much of my clinical time caring for people who have liver disease, including viral hepatitis and other liver conditions. For patients who require liver transplantation, I work closely with our surgeons at the NYU Langone Transplant Institute. I am also actively involved in the broader specialty of gastroenterology and gastrointestinal endoscopy, including upper gastrointestinal endoscopy and colonoscopy.

As the director of hepatology at NYU Langone Health, I aim to expand and enhance the clinical, research, and educational programs in liver disease and mentor the exceptional group of hepatologists here. It’s an honor to work with such a wonderful hepatology team and to provide patient care alongside world-class experts in medicine, surgery, pathology, radiology, oncology, and other specialties.

The primary source of gratification in my professional life is patient care. I enjoy meeting my patients and their families and hearing about their lives, and I pride myself on spending as much time with my patients as they need. While I focus on their specific conditions, I do so in the broad context of their overall health.

I place an emphasis on accessibility in my practice—my patients can contact me at any time through secure electronic communication. I also emphasize clear communication during office visits. We live in an era of “evidence-based medicine,” but existing medical evidence must sometimes be combined with clinical experience and judgment for the best approach to care. To do this, I provide individualized care and focus on each person and how he or she is unique.

For more than 30 years, I have participated in hundreds of clinical trials on antiviral therapy for viral hepatitis, including hepatitis B and C, and I have also led a number of them. These studies have remarkably improved our ability to treat people with these conditions, including the capacity to cure nearly all patients who have hepatitis C. I have authored and coauthored more than 250 scientific papers, chapters, and reviews on these and other topics. I continue to be involved in studies on viral hepatitis, and am also involved in studies examining treatments for other liver diseases, such as fatty liver disease and primary biliary cholangitis.

I am a fellow of several major organizations, including the American College of Physicians, the American Gastroenterological Association, the American Association for the Study of Liver Diseases, and the American College of Gastroenterology, and a member of the European Association for the Study of the Liver. Recently, I was honored to be elected to a fellowship at the Royal College of Physicians in the United Kingdom. I am a past president of the New York Society for Gastrointestinal Endoscopy and the New York Gastroenterological Association.

Conditions and Treatments

  • alcohol-related liver disease
  • alpha-1-antitrypsin deficiency
  • ascites, gastrointestinal
  • autoimmune hepatitis
  • autoimmune pancreatitis
  • bile duct cancer
  • bile duct cysts
  • bile duct disease
  • bile duct obstruction
  • bile duct stone
  • bile duct stricture
  • biliary disease
  • cholestasis
  • chronic liver disease
  • colon cancer
  • colon polyp
  • drug-induced liver injury
  • enlarged liver
  • esophageal varices
  • fatty liver disease
  • gallbladder disease
  • gallstone disease
  • Hemochromatosis
  • hepatic encephalopathy
  • hepatitis
  • hepatocellular carcinoma (hcc)
  • hepatorenal syndrome
  • liver adenoma
  • liver cancer
  • liver cirrhosis
  • liver cyst
  • liver disease
  • liver failure
  • liver fibrosis
  • liver function test abnormalities
  • liver tumor
  • liver varices
  • nodular regenerative hyperplasia
  • non-alcoholic fatty liver disease (nafld)
  • non-alcoholic steatohepatitis (nash)
  • portal hypertension
  • primary biliary cholangitis (pbc)
  • primary sclerosing cholangitis
  • varices, gastrointestinal
  • wilson's disease
  • colon cancer screening
  • colonoscopy
  • liver function test
  • polypectomy
  • transient elastography, liver (fibroscan)
  • upper endoscopy (egd)

Board Certifications
  • American Board of Internal Medicine (Gastroenterology), 1985
  • American Board of Internal Medicine - Internal Medicine, 1982
Education and Training
  • Fellowship, Harvard Medical School, Gastroenterology, 1984
  • Residency, University of California, San Francisco Medical Center, Internal Medicne, 1982
  • MD from Columbia University, 1979

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna International
    • Aetna Medicare Advantage
    • Aetna Open Access EPO
    • Aetna Open Access HMO
    • Aetna POS
    • Aetna POS (American Express Employer)
    • Aetna PPO
    • Aetna Signature Administrators PPO
    • Aetna Student Plan
    • Allied
    • Chesterfield Resources Inc
    • Christian Brothers Services
    • CoreSource
    • Nippon Life of America-Aetna
    • Nippon Life-Aetna
    • Starmark
    • WellNet
  • Anthem Blue Cross Blue Shield
    • Anthem BCBS CT PPO
    • Anthem BCBS CT Pathway PPO
    • BCBS Blue Access EPO Large Group
    • BCBS Blue Access EPO Small Group
    • BCBS Blue Access GEPO Small Group
    • BCBS Blue Access PPO Large Group
    • BCBS EPO
    • BCBS EPO (BlackRock Employees)
    • BCBS EPO (LICH Employees)
    • BCBS EPO - Empire EPO (NYU Langone Employees)
    • BCBS EPO - Empire EPO (Sunset Park/Family Health Center Employees)
    • BCBS EPO - Empire NYU Care (NYU Langone Employees)
    • BCBS EPO - Empire NYU Care (Sunset Park/Family Health Center Employees)
    • BCBS Federal Program
    • BCBS Florida Blue Care HMO
    • BCBS Florida Blue Medicare PPO
    • BCBS Florida Blue Options PPO
    • BCBS Florida Blue Select
    • BCBS Florida MyBlue HMO
    • BCBS Florida Simply Blue
    • BCBS Florida Traditional PPC
    • BCBS HMO
    • BCBS Indemnity
    • BCBS Local 32BJ Employees
    • BCBS Mediblue Medicare HMO
    • BCBS Mediblue Medicare PPO
    • BCBS Mediblue Select HMO/Extra HMO
    • BCBS POS
    • BCBS PPO
    • BCBS PPO (BlackRock Employees)
    • BCBS PPO (LICH Employees)
    • BCBS PPO - Empire PPO (Sunset Park/Family Health Center Employees)
    • BCBS PPO/EPO Small Group
    • New York Hotel Trades
  • Cigna
    • Apwu Health Plan
    • Cigna - Humana
    • Cigna Great West PPO
    • Cigna HMO
    • Cigna Indemnity
    • Cigna Managed Care/POS
    • Cigna Medicare Advantage
    • Cigna NALC
    • Cigna Open Access
    • Cigna Open Access PPO
    • Cigna Oscar
    • Cigna PPO
    • Cigna Premier Plus
    • Great West HMO
    • Kaiser Permanente
    • MVP-Cigna Network
    • Wellfleet-NYU Student
  • First Health
    • First Health PPO
  • GHI
    • GHI Medicare Supplement
  • Railroad Medicare
    • Palmetto GBA Railroad Medicare
  • Sedgwick WTC
    • World Trade Center - Sedgwick
  • United Healthcare
    • AARP Medicare Complete
    • Bind Benefits inc
    • Oxford Health Plans Medicare Advantage
    • UMR
    • Unite Healthcare (NY University Care Plan)
    • United Health Care Charter
    • United Healthcare AARP
    • United Healthcare All Savers
    • United Healthcare CareCore
    • United Healthcare Choice
    • United Healthcare Choice (AMEX employees)
    • United Healthcare Choice (Blackrock employees)
    • United Healthcare Choice (CBS employees)
    • United Healthcare Choice (Simon
    • United Healthcare Compass Exchange
    • United Healthcare EPO
    • United Healthcare EPO (NYU Langone Health Employees)
    • United Healthcare Golden Rule Insurance
    • United Healthcare HMO
    • United Healthcare Healthscope
    • United Healthcare Indemnity
    • United Healthcare Indemnity (NYU Langone Health Employees)
    • United Healthcare Medicare
    • United Healthcare Navigate
    • United Healthcare Nexus
    • United Healthcare Nexus (Amex Employees)
    • United Healthcare POS
    • United Healthcare PPO
    • United Healthcare Plus (NYU Langone Health Employees)
    • United Healthcare Student Resources
    • United Healthcare Student Resources (NYU)
    • United Healthcare Value, Advantage and HDHP (New York University employees)
    • UnitedHealthcare Choice (NY Power Authority Employees)
  • VA Community Care Network
    • VA CCN Optum
  • WTC Health Program
    • NY Fire Department - WTC
    • WTC Health Program
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Ira M. Jacobson, MD does not accept insurance.

Locations and Appointments

NYU Langone Gastroenterology and Hepatology Associates

150 East 32nd Street, Suite 101, New York, NY 10016


Hepatitis, Fatty liver disease, Priimary biliary choangitis, primary sclerosing cholangitis

Academic Contact

Academic office

240 East 38th Street

23rd Floor

New York, NY 10016





  • Tirzepatide is a 39-amino acid synthetic peptide with agonist activity at both the glucosedependent insulinotropic polypeptide gastric inhibitory polypeptide (GIP) receptor and the glucagon-like peptide-1 receptor. Its structure is based on the GIP sequen

    Learn More
  • This is an open label uncontrolled international multicenter long-term observational study. The study will include subjects who participated in a previous PBC study with seladelpar (CB8025-21629 CB8025-31735 or CB8025-21838) or future PBC studies with

    Learn More
  • Overview: This Phase 2a randomized DB active-controlled parallel-group study will evaluate the efficacy safety and tolerability of OCA (5 mg/day) administered in combination with two different BZF doses (100 and 400 mg/day) compared to BZF alone (10

    Learn More
View All Research Studies (15)

Read All Publications (482)

Related News